Skip to search formSkip to main contentSkip to account menu

cetiedil

Known as: alpha-Cyclohexyl-3-thiopheneacetic acid, 2-(hexahydro-1H-azepin-1-yl)ethyl ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Abstract: Synaptic vesicles purified on a sucrose‐KCl sedimentation gradient were tested for their ability to accumulate [l‐14C… 
Highly Cited
1984
1984
1984
Two new vascular smooth muscle relaxants, bepridil and cetiedil, were found to possess specific CaM-inhibitory properties which… 
1982
1982
Cetiedil is a potential antisickling agent whose major effect appears to be at the erythrocyte membrane. To test the hypothesis… 
1982
1982
Cetiedil, a drug reported to relieve painful crises in sickle cell anemia, has direct antisickling properties in vitro. However… 
Highly Cited
1981
Highly Cited
1981
Cetiedil has been reported to relieve painful crises in sickle cell anemia and to have antisickling properties in vitro. The drug… 
1980
1980
Cetiedil used clinically in cases of chronic cardiovascular disease in Europe was found to inhibit sickling and improve the… 
1980
1980
The antisickling effect of cetiedil, alpha-cyclohexyl-3-thiopheneacetic acid 2-(hexahydro-1H-azepin-1-yl)-ethyl ester, has been… 
1976
1976
The cardiovascular effects of progressively increasing infusions of papaverine hydrochloride, aminophylline and cetiedil, a new…